EPCAM and carcinoma: In this respect, transient siRNA-mediated silencing of EpCAM expression has been shown to reduce the oncogenic potential of breast (Osta et al, 2004), gastric (Du et al, 2009), hepatocellular (Yamashita et al, 2009) and oral squamous cell (Yanamoto et al, 2007) carcinomas.